Seek Returns logo

SOLV vs. UHS: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at SOLV and UHS, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolSOLVUHS
Company NameSolventum CorporationUniversal Health Services, Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Equipment & SuppliesHealth Care Providers & Services
Market Capitalization12.63 billion USD11.75 billion USD
ExchangeNYSENYSE
Listing DateMarch 26, 2024July 9, 1981
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of SOLV and UHS by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

SOLV vs. UHS: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolSOLVUHS
5-Day Price Return-0.48%3.33%
13-Week Price Return-3.85%-6.16%
26-Week Price Return-1.96%1.03%
52-Week Price Return22.54%-18.82%
Month-to-Date Return2.09%10.96%
Year-to-Date Return10.28%2.94%
10-Day Avg. Volume1.86M0.73M
3-Month Avg. Volume1.00M0.89M
3-Month Volatility23.47%31.65%
Beta0.851.30

Profitability

Return on Equity (TTM)

SOLV

11.61%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

SOLV’s Return on Equity of 11.61% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.

UHS

18.62%

Health Care Providers & Services Industry

Max
26.03%
Q3
13.74%
Median
8.26%
Q1
4.13%
Min
-3.62%

In the upper quartile for the Health Care Providers & Services industry, UHS’s Return on Equity of 18.62% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

SOLV vs. UHS: A comparison of their Return on Equity (TTM) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Net Profit Margin (TTM)

SOLV

4.52%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

Falling into the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s Net Profit Margin of 4.52% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

UHS

7.66%

Health Care Providers & Services Industry

Max
12.40%
Q3
5.93%
Median
1.96%
Q1
0.93%
Min
-6.10%

A Net Profit Margin of 7.66% places UHS in the upper quartile for the Health Care Providers & Services industry, signifying strong profitability and more effective cost management than most of its peers.

SOLV vs. UHS: A comparison of their Net Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Operating Profit Margin (TTM)

SOLV

9.26%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

SOLV’s Operating Profit Margin of 9.26% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.

UHS

10.99%

Health Care Providers & Services Industry

Max
19.05%
Q3
10.21%
Median
4.22%
Q1
1.98%
Min
-4.27%

An Operating Profit Margin of 10.99% places UHS in the upper quartile for the Health Care Providers & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

SOLV vs. UHS: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Profitability at a Glance

SymbolSOLVUHS
Return on Equity (TTM)11.61%18.62%
Return on Assets (TTM)2.58%8.60%
Net Profit Margin (TTM)4.52%7.66%
Operating Profit Margin (TTM)9.26%10.99%
Gross Profit Margin (TTM)54.65%--

Financial Strength

Current Ratio (MRQ)

SOLV

1.22

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

SOLV’s Current Ratio of 1.22 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

UHS

1.29

Health Care Providers & Services Industry

Max
2.01
Q3
1.49
Median
1.30
Q1
0.94
Min
0.17

UHS’s Current Ratio of 1.29 aligns with the median group of the Health Care Providers & Services industry, indicating that its short-term liquidity is in line with its sector peers.

SOLV vs. UHS: A comparison of their Current Ratio (MRQ) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

SOLV

2.14

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

With a Debt-to-Equity Ratio of 2.14, SOLV operates with exceptionally high leverage compared to the Health Care Equipment & Supplies industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

UHS

0.65

Health Care Providers & Services Industry

Max
2.17
Q3
1.18
Median
0.74
Q1
0.45
Min
0.00

UHS’s Debt-to-Equity Ratio of 0.65 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

SOLV vs. UHS: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Interest Coverage Ratio (TTM)

SOLV

2.65

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

In the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s Interest Coverage Ratio of 2.65 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.

UHS

9.05

Health Care Providers & Services Industry

Max
14.47
Q3
7.15
Median
5.45
Q1
2.04
Min
-4.44

UHS’s Interest Coverage Ratio of 9.05 is in the upper quartile for the Health Care Providers & Services industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

SOLV vs. UHS: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Financial Strength at a Glance

SymbolSOLVUHS
Current Ratio (MRQ)1.221.29
Quick Ratio (MRQ)0.861.19
Debt-to-Equity Ratio (MRQ)2.140.65
Interest Coverage Ratio (TTM)2.659.05

Growth

Revenue Growth

SOLV vs. UHS: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

SOLV vs. UHS: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

SOLV

0.00%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

SOLV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

UHS

0.45%

Health Care Providers & Services Industry

Max
5.38%
Q3
2.22%
Median
0.55%
Q1
0.00%
Min
0.00%

UHS’s Dividend Yield of 0.45% is consistent with its peers in the Health Care Providers & Services industry, providing a dividend return that is standard for its sector.

SOLV vs. UHS: A comparison of their Dividend Yield (TTM) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Dividend Payout Ratio (TTM)

SOLV

0.00%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

SOLV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

UHS

4.19%

Health Care Providers & Services Industry

Max
186.69%
Q3
74.82%
Median
26.76%
Q1
0.00%
Min
0.00%

UHS’s Dividend Payout Ratio of 4.19% is within the typical range for the Health Care Providers & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

SOLV vs. UHS: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Dividend at a Glance

SymbolSOLVUHS
Dividend Yield (TTM)0.00%0.45%
Dividend Payout Ratio (TTM)0.00%4.19%

Valuation

Price-to-Earnings Ratio (TTM)

SOLV

33.33

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

SOLV’s P/E Ratio of 33.33 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

UHS

9.33

Health Care Providers & Services Industry

Max
55.89
Q3
30.85
Median
21.17
Q1
12.63
Min
0.00

In the lower quartile for the Health Care Providers & Services industry, UHS’s P/E Ratio of 9.33 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

SOLV vs. UHS: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

SOLV

1.51

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

In the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s P/S Ratio of 1.51 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

UHS

0.71

Health Care Providers & Services Industry

Max
3.10
Q3
1.74
Median
0.67
Q1
0.24
Min
0.00

UHS’s P/S Ratio of 0.71 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

SOLV vs. UHS: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

SOLV

3.60

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

SOLV’s P/B Ratio of 3.60 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

UHS

1.66

Health Care Providers & Services Industry

Max
7.61
Q3
4.32
Median
2.53
Q1
1.14
Min
0.77

UHS’s P/B Ratio of 1.66 is within the conventional range for the Health Care Providers & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

SOLV vs. UHS: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Equipment & Supplies and Health Care Providers & Services industry benchmarks.

Valuation at a Glance

SymbolSOLVUHS
Price-to-Earnings Ratio (TTM)33.339.33
Price-to-Sales Ratio (TTM)1.510.71
Price-to-Book Ratio (MRQ)3.601.66
Price-to-Free Cash Flow Ratio (TTM)54.9213.05